MedPath

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States
Ownership
-
Established
1811-01-01
Employees
-
Market Cap
-
Website
http://www.massgeneral.org/international

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Not Applicable
Active, not recruiting
Conditions
Advanced Lung Cancer
Small Cell Lung Cancer Extensive Stage
Stage IV Gastric Cancer
Stage IV Hepatocellular Cancer
Unresectable Stage III Non-Small Cell Lung Cancer
Stage IV Basal Cell Carcinoma
Stage IV Esophageal Cancer
Stage IV Cutaneous Squamous Cell Carcinoma
Stage IV Renal Cell Carcinoma
Stage IV Head and Neck Squamous Cell Carcinoma
Interventions
Other: Usual Care
Other: Educational Video and QPL List
First Posted Date
2020-12-17
Last Posted Date
2023-10-23
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
210
Registration Number
NCT04670445
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

Transcranial Photobiomodulation With Near-Infrared Light for Language in Individuals With Down Syndrome

Not Applicable
Active, not recruiting
Conditions
Down Syndrome
Interventions
Device: Near-Infrared Transcranial Photobiomodulation
Device: Sham Transcranial Photobiomodulation
First Posted Date
2020-12-16
Last Posted Date
2024-05-31
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
19
Registration Number
NCT04668001
Locations
🇺🇸

Massachusetts General Hospital at the Charlestown Navy Yard, Charlestown, Massachusetts, United States

Biomarkers to Predict and Monitor Response to Infliximab

Conditions
Crohn Disease
First Posted Date
2020-12-07
Last Posted Date
2022-04-13
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
120
Registration Number
NCT04655729
Locations
🇺🇸

MassGeneral for Children, Boston, Massachusetts, United States

Folfox+Irinotecan+Chemort In Esophageal Cancer

Phase 2
Recruiting
Conditions
Esophagogastric Cancer
Gastroesophageal Junction Adenocarcinoma
Interventions
Drug: FOLFOX/ nal-IRI
Radiation: Proton Radiation Therapy
First Posted Date
2020-12-07
Last Posted Date
2022-09-08
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
40
Registration Number
NCT04656041
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

🇺🇸

Beth-Israel Deaconess Medical Center, Boston, Massachusetts, United States

🇺🇸

Massachusetts General Hospital at Newton Wellesley Hospital, Newton, Massachusetts, United States

Neuroimaging Study of Dexmedetomidine-Induced Analgesia

Phase 2
Conditions
Anesthesia
Analgesia
Interventions
First Posted Date
2020-12-07
Last Posted Date
2022-03-31
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
20
Registration Number
NCT04656470
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

Ruxolitinib in Thrombocythemia and Polycythemia Vera

Phase 2
Recruiting
Conditions
Essential Thrombocythemia
Polycythemia Vera
Interventions
First Posted Date
2020-11-25
Last Posted Date
2024-03-08
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
60
Registration Number
NCT04644211
Locations
🇺🇸

Beth-Israel Deaconess Medical Center, Boston, Massachusetts, United States

🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

🇺🇸

Dana Farber Cancer Institute, Boston, Massachusetts, United States

Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

Phase 2
Withdrawn
Conditions
Immunotherapy
Cutaneous Squamous Cell Carcinoma
Actinic Keratoses
Organ Transplant Recipients
Skin Cancer
Interventions
First Posted Date
2020-11-24
Last Posted Date
2025-05-07
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
64
Registration Number
NCT04642287
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

🇺🇸

Barnes-Jewish Hospital, Saint Louis, Missouri, United States

Care Transition Intervention for Patients With Cancer

Not Applicable
Completed
Conditions
Home Care, Hospital-Based
Advanced Cancer
Interventions
Behavioral: CONTINUity of care Under Management by Video visits (CONTINUUM-V)
First Posted Date
2020-11-23
Last Posted Date
2021-11-19
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
58
Registration Number
NCT04640714
Locations
🇺🇸

Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States

Supportive Oncology Care at Home Post-Discharge

Not Applicable
Active, not recruiting
Conditions
Cancer
Interventions
Other: Supportive Oncology Care at Home
First Posted Date
2020-11-19
Last Posted Date
2025-04-15
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
110
Registration Number
NCT04637035
Locations
🇺🇸

Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States

Precision Medicine in Ischemic Stroke and Atrial Fibrillation

Not Applicable
Completed
Conditions
Atrial Fibrillation
Ischemic Stroke
Interventions
Other: Atrial fibrillation risk electronic health record alert
First Posted Date
2020-11-19
Last Posted Date
2025-05-07
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
805
Registration Number
NCT04637087
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath